Based on this study, our previous data [16] and reports by others [36], our interpretation of the observed p53 binding differences is that they reflect the cancer–associated epigenetic changes accumulated in HCT116 cells (absent from IMR90), superimposed on tissue specific differences (HCT116 has epithelial, while IMR90 has mesenchymal origin). This evidence concerns the gene TP53 and cancer.